Cohort study of cardiovascular safety of different COVID-19 vaccination doses among 46 million adults in England

Cohort study of cardiovascular safety of different COVID-19 vaccination doses among 46 million adults in England

Abstract The first dose of COVID-19 vaccines led to an overall reduction in cardiovascular events, and in rare cases, cardiovascular complications. There is less information about the effect of second and booster doses on cardiovascular diseases. Using longitudinal health records from 45.7 million a...

Full description

Bibliographic Details
Main Authors: Samantha Ip, Teri-Louise North, Fatemeh Torabi, Yangfan Li, Hoda Abbasizanjani, Ashley Akbari, Elsie Horne, Rachel Denholm, Spencer Keene, Spiros Denaxas, Amitava Banerjee, Kamlesh Khunti, Cathie Sudlow, William N. Whiteley, Jonathan A. C. Sterne, Angela M. Wood, Venexia Walker, the CVD-COVID-UK/COVID-IMPACT Consortium, the Longitudinal Health and Wellbeing COVID-19 National Core Study
Format: Article
Language:English
Published: Nature Portfolio 2024-07-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-024-49634-x

Internet

https://doi.org/10.1038/s41467-024-49634-x

Similar Items